DE3688333D1 - Antikoerper gegen polypeptide, die gegen peptide oder proteine mit mindestens teilweise bekannter aminosaeure oder kodierender nukleotidsequenz komplementaer sind und diesbezuegliches aufbauverfahren. - Google Patents

Antikoerper gegen polypeptide, die gegen peptide oder proteine mit mindestens teilweise bekannter aminosaeure oder kodierender nukleotidsequenz komplementaer sind und diesbezuegliches aufbauverfahren.

Info

Publication number
DE3688333D1
DE3688333D1 DE8989106162T DE3688333T DE3688333D1 DE 3688333 D1 DE3688333 D1 DE 3688333D1 DE 8989106162 T DE8989106162 T DE 8989106162T DE 3688333 T DE3688333 T DE 3688333T DE 3688333 D1 DE3688333 D1 DE 3688333D1
Authority
DE
Germany
Prior art keywords
complementaries
proteins
amino acids
nucleotide sequences
assembly procedure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE8989106162T
Other languages
English (en)
Other versions
DE3688333T2 (de
Inventor
Edwin J Blalock
Kenneth L Bost
Eric M Smith
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Texas System
Original Assignee
University of Texas System
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/708,001 external-priority patent/US4863857A/en
Application filed by University of Texas System filed Critical University of Texas System
Application granted granted Critical
Publication of DE3688333D1 publication Critical patent/DE3688333D1/de
Publication of DE3688333T2 publication Critical patent/DE3688333T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/18—Testing for antimicrobial activity of a material
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6878—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids in eptitope analysis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/665—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • C07K14/695—Corticotropin [ACTH]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/44—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material not provided for elsewhere, e.g. haptens, metals, DNA, RNA, amino acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/803—Physical recovery methods, e.g. chromatography, grinding
DE89106162T 1985-03-01 1986-02-24 Antikörper gegen Polypeptide, die gegen Peptide oder Proteine mit mindestens teilweise bekannter Aminosäure oder kodierender Nukleotidsequenz komplementär sind und diesbezügliches Aufbauverfahren. Expired - Fee Related DE3688333T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/708,001 US4863857A (en) 1985-03-01 1985-03-01 Polypeptide complementary to peptides or proteins having an amino acid sequence or nucleotide coding sequence at least partially known
US06/829,709 US5077195A (en) 1985-03-01 1986-02-19 Polypeptides complementary to peptides or proteins having an amino acid sequence or nucleotide coding sequence at least partially known and methods of design therefor

Publications (2)

Publication Number Publication Date
DE3688333D1 true DE3688333D1 (de) 1993-05-27
DE3688333T2 DE3688333T2 (de) 1993-10-28

Family

ID=27108003

Family Applications (2)

Application Number Title Priority Date Filing Date
DE89106162T Expired - Fee Related DE3688333T2 (de) 1985-03-01 1986-02-24 Antikörper gegen Polypeptide, die gegen Peptide oder Proteine mit mindestens teilweise bekannter Aminosäure oder kodierender Nukleotidsequenz komplementär sind und diesbezügliches Aufbauverfahren.
DE8686901662T Expired - Fee Related DE3679017D1 (de) 1985-03-01 1986-02-24 Komplementaere polypeptide gegen peptide oder proteine mit mindestens teilweise bekannter aminosaeure- oder nukleotidkodierender sequenz und diesbezuegliches aufbauverfahren.

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE8686901662T Expired - Fee Related DE3679017D1 (de) 1985-03-01 1986-02-24 Komplementaere polypeptide gegen peptide oder proteine mit mindestens teilweise bekannter aminosaeure- oder nukleotidkodierender sequenz und diesbezuegliches aufbauverfahren.

Country Status (18)

Country Link
US (2) US5077195A (de)
EP (2) EP0214232B1 (de)
JP (1) JPH07215999A (de)
KR (1) KR920002315B1 (de)
AT (2) ATE63138T1 (de)
AU (1) AU592781B2 (de)
BR (1) BR8606615A (de)
CA (1) CA1339606C (de)
DE (2) DE3688333T2 (de)
DK (1) DK521386A (de)
ES (3) ES8705919A1 (de)
FI (1) FI90255C (de)
GR (1) GR860576B (de)
IE (1) IE58837B1 (de)
IL (1) IL96043A0 (de)
NO (1) NO174971C (de)
PT (1) PT82132B (de)
WO (1) WO1986005208A1 (de)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3587549T2 (de) * 1984-10-29 1994-02-17 Microgenics Corp Ergänzungstestverfahren von proteine bindenden enzymen.
DE3527568A1 (de) * 1985-08-01 1987-02-05 Bissendorf Peptide Gmbh Synthetische peptidrezeptoren, verfahren zur herstellung und verwendung derselben
CA1297003C (en) * 1985-09-20 1992-03-10 Jack H. Nunberg Composition and method for treating animals
WO1987005029A2 (en) * 1986-02-19 1987-08-27 Triton Biosciences Inc Peptides affecting blood pressure regulation
US4772684A (en) * 1987-01-20 1988-09-20 Triton Biosciences, Inc. Peptides affecting blood pressure regulation
JPH02104595A (ja) * 1988-03-04 1990-04-17 Univ Alabama 非ペプチドのペプチド相当物及びそのデザイン方法
DE69033395D1 (de) * 1989-07-31 2000-01-20 Tecnogen Scpa Verfahren zur Identifizierung und Herstellung von Bindungsstellen aufeinanderwirkender Proteine
US5324512A (en) * 1990-12-26 1994-06-28 The Population Council [Gln']-luteinizing hormone releasing hormone conjugate of tetanus vaccine and its uses
JPH05262788A (ja) * 1991-09-03 1993-10-12 Hitachi Chem Co Ltd ペプチド類、その設計方法及び製造方法並びに受容体上の生理活性ペプチドの結合部位の決定方法
US6017512A (en) * 1992-06-23 2000-01-25 Diatide, Inc. Radiolabeled peptides
US5620675A (en) 1992-06-23 1997-04-15 Diatech, Inc. Radioactive peptides
EP0672421B1 (de) * 1993-10-07 2002-03-20 Kurashiki Boseki Kabushiki Kaisha Hemmer der aktivität von endothelin
US6051206A (en) * 1994-06-03 2000-04-18 Diatide, Inc Radiolabeled somatostatin-derived peptides for imaging and therapeutic uses
IL115177A0 (en) * 1994-09-16 1995-12-31 Immunomedics Inc Phosphorus-32 labeling of antibodies for cancer therapy
US5523208A (en) * 1994-11-30 1996-06-04 The Board Of Trustees Of The University Of Kentucky Method to discover genetic coding regions for complementary interacting proteins by scanning DNA sequence data banks
JP3737516B2 (ja) * 1995-06-26 2006-01-18 パーセプティブ バイオシステムズ，インコーポレーテッド 高速自動化連続流、多次元分子選別および分析
US5807552A (en) * 1995-08-04 1998-09-15 Board Of Regents, The University Of Texas System Compositions for conferring immunogenicity to a substance and uses thereof
WO1999027964A1 (en) * 1997-12-01 1999-06-10 Cfy Biomedicals, Inc. Multivalent recombinant antibodies for treating hrv infections
DE19805334A1 (de) * 1998-02-11 1999-08-12 Otogene Biotechnologische Fors Verfahren zur Entwicklung eines pharmazeutischen Wirkstoffes
WO1999055911A1 (en) * 1998-04-24 1999-11-04 Fang Fang Identifying peptide ligands of target proteins with target complementary library technology (tclt)
US20030035798A1 (en) * 2000-08-16 2003-02-20 Fang Fang Humanized antibodies
ES2316356T3 (es) * 1999-03-09 2009-04-16 Fornix Biosciences N.V. Peptidos sinteticos complementarios y sus utilizaciones oftalmologicas.
GB2356401A (en) * 1999-11-19 2001-05-23 Proteom Ltd Method for manipulating protein or DNA sequence data
GB9929466D0 (en) * 1999-12-13 2000-02-09 Proteom Ltd Complementary peptide ligands generated from microbial genome sequences
GB9929469D0 (en) * 1999-12-13 2000-02-09 Proteom Ltd Complementary peptide ligands generated from plant genomes
GB9929464D0 (en) * 1999-12-13 2000-02-09 Proteom Ltd Complementary peptide ligande generated from the human genome
AU2001294822A1 (en) * 2000-09-26 2002-04-08 Geneformatics, Inc. Methods for determining aproximations of three dimensional polypeptide structure
GB0025251D0 (en) * 2000-10-14 2000-11-29 Proteom Ltd Antisense peptides to Fc receptors and their uses
EP2365062B1 (de) * 2001-02-20 2016-11-23 University Of Georgia Research Foundation, Inc. Schnelle Herstellung monoklonaler Antikörper
WO2003062370A2 (en) 2001-07-19 2003-07-31 Perlan Therapeutics, Inc. Multimeric proteins and methods of making and using same
WO2008157236A1 (en) * 2007-06-14 2008-12-24 The Board Of Regents For Oklahoma State University Vaccines containing canine parvovirus genetic variants
US8227583B2 (en) * 2007-06-14 2012-07-24 The Board Of Regents For Oklahoma State University Vaccines containing canine parvovirus genetic variants
US20190062373A1 (en) * 2017-08-30 2019-02-28 Peption, LLC Method of generating interacting peptides

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6936694B1 (en) * 1982-05-06 2005-08-30 Intermune, Inc. Manufacture and expression of large structural genes

Also Published As

Publication number Publication date
NO174971C (no) 1994-08-10
JPH07215999A (ja) 1995-08-15
US5212072A (en) 1993-05-18
ES8800267A1 (es) 1987-11-01
AU5510286A (en) 1986-09-24
EP0332225B1 (de) 1993-04-21
NO174971B (no) 1994-05-02
FI90255C (fi) 1994-01-10
DK521386D0 (da) 1986-10-31
EP0332225A2 (de) 1989-09-13
CA1339606C (en) 1997-12-30
ATE63138T1 (de) 1991-05-15
NO864369D0 (no) 1986-10-31
DE3688333T2 (de) 1993-10-28
KR920002315B1 (ko) 1992-03-21
ES8800266A1 (es) 1987-11-01
ES8705919A1 (es) 1987-05-16
FI864427A0 (fi) 1986-10-30
ES557188A0 (es) 1987-11-01
EP0214232B1 (de) 1991-05-02
DK521386A (da) 1986-12-29
ES552534A0 (es) 1987-05-16
IE58837B1 (en) 1993-11-17
GR860576B (en) 1986-07-01
PT82132B (pt) 1989-05-31
WO1986005208A1 (en) 1986-09-12
PT82132A (en) 1986-04-01
KR870700100A (ko) 1987-02-28
ES557189A0 (es) 1987-11-01
EP0214232A1 (de) 1987-03-18
NO864369L (no) 1987-01-02
IE860527L (en) 1986-09-01
BR8606615A (pt) 1987-08-11
AU592781B2 (en) 1990-01-25
IL96043A0 (en) 1991-07-18
DE3679017D1 (de) 1991-06-06
FI864427A (fi) 1986-10-30
US5077195A (en) 1991-12-31
EP0332225A3 (en) 1989-09-27
ATE88572T1 (de) 1993-05-15
FI90255B (fi) 1993-09-30

Similar Documents

Publication Publication Date Title
DE3688333D1 (de) Antikoerper gegen polypeptide, die gegen peptide oder proteine mit mindestens teilweise bekannter aminosaeure oder kodierender nukleotidsequenz komplementaer sind und diesbezuegliches aufbauverfahren.
DE3856560D1 (de) Dem menschlichen gewebefaktor ähnliche dns-segmente, polypeptide und antikörper
DK532284A (da) Fremgangsmaade til bestemmelse af antigenaktive aminosyresekvenser
LU91014I2 (fr) Kogentate (Octocog alfa) dans toutes ses formes couvertes par le brevet de base
KR970702917A (ko) Lag-3의 가용성 폴리펩타이드 절편 및 생산 방법, 치료 조성물, 항-이디오타입 항체
CA2124953A1 (en) Peptides related to prion proteins
PL393286A1 (pl) Rozpuszczalny receptor BR43x2 i sposoby jego zastosowania
ATE226248T1 (de) Anticaline
ATE50458T1 (de) Bestimmung von fibrin mit fibrin-spezifischen antikoerpern.
PT639225E (pt) Polipeptidos e peptidos novos acidos nucleicos que codificam para aqueles e sua utilizacao na area da terapia tumoral inflamacao ou imunologia
DE3782549D1 (de) Neue polypeptide, ihre herstellung und ihre verwendung.
DE69832299D1 (de) Einkettigen polypeptiden enthalten troponin i und troponin c
AU2676399A (en) Novel cystine knot protein and materials and methods for making it
Roholt et al. A light chain tyrosyl sequence in the antibody site of a rabbit anti-p-azobenzoate antibody
ATE317851T1 (de) Polypeptide mit aminosäuresequenzen aus dem n- terminalen bereich von gp116 von cytomegalovirus und deren verwendung bei der diagnostik, prophylaxe und therapie

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee